- Home
- UONE vs CTSO Comparison
UONE vs CTSO Comparison
Compare UONE & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UONE
- CTSO
- Stock Information
- Founded
- UONE 1980
- CTSO 1997
- Country
- UONE United States
- CTSO United States
- Employees
- UONE N/A
- CTSO N/A
- Industry
- UONE Broadcasting
- CTSO Medical/Dental Instruments
- Sector
- UONE Consumer Discretionary
- CTSO Health Care
- Exchange
- UONE Nasdaq
- CTSO Nasdaq
- Market Cap
- UONE 70.8M
- CTSO 61.7M
- IPO Year
- UONE N/A
- CTSO N/A
- Fundamental
- Price
- UONE $1.46
- CTSO $0.90
- Analyst Decision
- UONE
- CTSO Buy
- Analyst Count
- UONE 0
- CTSO 2
- Target Price
- UONE N/A
- CTSO $5.50
- AVG Volume (30 Days)
- UONE 19.2K
- CTSO 130.7K
- Earning Date
- UONE 11-06-2025
- CTSO 11-06-2025
- Dividend Yield
- UONE N/A
- CTSO N/A
- EPS Growth
- UONE N/A
- CTSO N/A
- EPS
- UONE N/A
- CTSO N/A
- Revenue
- UONE $411,386,000.00
- CTSO $36,107,520.00
- Revenue This Year
- UONE N/A
- CTSO $11.93
- Revenue Next Year
- UONE N/A
- CTSO $21.22
- P/E Ratio
- UONE N/A
- CTSO N/A
- Revenue Growth
- UONE N/A
- CTSO 20.18
- 52 Week Low
- UONE $1.23
- CTSO $0.71
- 52 Week High
- UONE $2.02
- CTSO $1.61
- Technical
- Relative Strength Index (RSI)
- UONE 41.14
- CTSO 42.05
- Support Level
- UONE $1.37
- CTSO $0.87
- Resistance Level
- UONE $1.63
- CTSO $1.04
- Average True Range (ATR)
- UONE 0.12
- CTSO 0.05
- MACD
- UONE -0.01
- CTSO -0.00
- Stochastic Oscillator
- UONE 18.75
- CTSO 21.95
About UONE Urban One Inc.
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.